Abstract
A rapid, quantitative, and nonsubjective method of interferon assay is described, which can be readily applied to clinical specimens. Automated data acquisition and data reduction allowed a significant increase in volume per unit of time over existing methodologies. Plasma always yielded higher (usually 2:1) interferon values than did serum obtained simultaneously. Ranges of interferon levels in plasma in normal control populations are reported as well as ranges for clinical virology laboratory technicians and patients with terminal malignancies or collagen vascular diseases.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carter W. A., Horoszewicz J. S. Production, purification and clinical application of human fibroblast interferon. Pharmacol Ther. 1980;8(2):359–377. doi: 10.1016/0163-7258(80)90053-4. [DOI] [PubMed] [Google Scholar]
- McManus N. H. Microtiter assay for interferon: microspectrophotometric quantitation of cytopathic effect. Appl Environ Microbiol. 1976 Jan;31(1):35–38. doi: 10.1128/aem.31.1.35-38.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitchell W. M., Forti R. L. Progress in the monitoring of human interferon in body fluids and the phenotypic expression of human interferon activity. Prog Clin Pathol. 1984;9:101–119. [PubMed] [Google Scholar]
- Preble O. T., Black R. J., Friedman R. M., Klippel J. H., Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science. 1982 Apr 23;216(4544):429–431. doi: 10.1126/science.6176024. [DOI] [PubMed] [Google Scholar]
- Rubinstein S., Familletti P. C., Pestka S. Convenient assay for interferons. J Virol. 1981 Feb;37(2):755–758. doi: 10.1128/jvi.37.2.755-758.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]